Effects of Intra-uterine Slow-Release Insemination on Pregnancy Rate in Women Designated for Artificial Insemination
Testing the Effect of Intra-uterine Slow-Release Insemination (SRI) on the Pregnancy Rate in Women Designated for Artificial Insemination
1 other identifier
interventional
100
1 country
1
Brief Summary
A couple that does not achieve pregnancy though regular attempts for a year are defined infertile couple. This condition is caused by faulty functioning of the reproduction system of the husband or wife or both. If there are no organic defects and there is no definite injury to the reproductive system (ova or spermatozoa), the specialist doctor generally decides to put the couple into a fertility treatment program. Artificial insemination is one of the important ways of achieving pregnancy. Three common methods of artificial insemination:
- Very close approximation of the natural procedure in which the spermatozoa arrive to the fertilization site over a long period.
- An extended "window of opportunities" for meeting between the ovum and spermatozoa will be longer.
- There is no loss of spermatozoa due to leaking as sometimes happens with single-time injection practiced in the IUI method. Primary Endpoint: Accumulation of 50 cycles of SRI- slow release insemination (study group) in addition to 50 cycles of regular IUI (control group). Two weeks after insemination Beta hCG test Secondary Endpoints: Four weeks after insemination - US Viability scan Procedure: Subjects will be women with fertility difficulties who are designated for IUI treatment. 100 insemination cycles will be conducted. (50 regular IUI and 50 EVIE-SRI). Subjects that were treated with the IUI method and who does not become pregnant will then be treated with the EVIE-Slow Release method and vice versa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2008
CompletedFirst Posted
Study publicly available on registry
September 3, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJune 9, 2011
December 1, 2008
8 months
August 30, 2008
June 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accumulation of 50 cycles of SRI- slow release insemination (study group) in addition to 50 cycles of regular IUI (control group). Two weeks after insemination Beta hCG test
2 weeks following procedure
Secondary Outcomes (1)
Four weeks after insemination - US Viability scan
4 weeks following procedure
Study Arms (1)
A
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Primary or secondary infertility designated for IUI treatment.
- Age of candidates: 20-40 years.
- Normal uterus x-ray.
- Women suffering from infertility on a background of non-ovulation.
- Infertility on a background of male problems (over 10 million of motile sperm cells per sample).
- Infertility on background of unexplained problem
- Same sex patients / single patient
- Written informed consent
You may not qualify if:
- Woman under the age of 20 or over the age of 40 years.
- Female infertility on mechanical background (different blockages, irregular uterus).
- Infertility on male background of medium to very low level of spermatozoa - less than 10 million motile sperm cells per sample.
- Men and women who are opposed to the random spermatozoa insemination method.
- Participants who are not willing to sign the Consent Form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fertiligentlead
Study Sites (1)
Carmel Medical Center
Haifa, 31048, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martha Dirnfeld, Prof.
Carmel medical Center, Haifa Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
August 30, 2008
First Posted
September 3, 2008
Study Start
October 1, 2008
Primary Completion
June 1, 2009
Study Completion
December 1, 2009
Last Updated
June 9, 2011
Record last verified: 2008-12